Abstract
Despite the significant advances in the medical research and treatment methods, the rate of mortality associated with cardiovascular disease (CVD) is continuously rising and it remains the leading cause of death worldwide. There are several treatment methods for CVD and associated complications that have been considered till now. The current treatment methods cannot produce rapid cure, but could prevent or reduce the progression of this devastating disease. In the current article, we have summarized the use of various pharmacological agents viz. HMG-CoA reductase inhibitors (statins), antihypertensive, thrombolytic and anticoagulation agents that are currently being used for the management of CVD which targets different biochemical or molecular events. Based on our article, more research in this field is advocated which will provide the rapid and effective treatment methods in order to avoid fatal complications associated with CVD.
| Original language | English |
|---|---|
| Pages (from-to) | 566-571 |
| Number of pages | 6 |
| Journal | Current Pharmaceutical Design |
| Volume | 22 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 1 Feb 2016 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anticoagulation agents
- Antihypertensive agents
- Antithrombolytic agents
- Statins
Fingerprint
Dive into the research topics of 'Current updates on therapeutic advances in the management of cardiovascular diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver